Heart Disease in Cats

Paige, C. F., J. A. Abbott, et al. (2009). "Prevalence of cardiomyopathy in apparently healthy cats." J Am Vet Med Assoc 234(11): 1398-1403.

The purpose of the study was to determine the prevalence of cardiomyopathy and the relationship between cardiomyopathy and heart murmurs in apparently healthy cats. The study included 103 privately owned and apparently healthy cats that were physically and echocardiographically examined independently by two investigators. Left ventricular wall thickness was determined using 2-dimensional echocardiography in short-axis and long-axis views. Sixteen of the cats examined had heart murmurs detected; of these, 5 had cardiomyopathy. Cardiomyopathy was also identified in 16 cats; 15 had hypertrophic cardiomyopathy (HCM), and one had arrhythmogenic right ventricular cardiomyopathy. The sensitivity and specificity of auscultatory detection of a heart murmur for diagnosis of cardiomyopathy were 31% and 87%, respectively. The findings of this study indicated that cardiomyopathy is common in healthy cats. In addition, detection of a heart murmur is not a reliable indicator of cardiomyopathy in apparently healthy cats. [VT]
>> PubMed Abstract

Related articles:
Rush, J., L. Freeman, et al. (2002). "Population and survival characteristics of cats with hypertrophic cardiomyopathy: 260 cases (1990-1999)." J Amer Vet Med Assoc 220(2): 202-207.
>> PubMed Abstract

Zimmering, T. M., F. Meneses, et al. (2009). "Measurement of N-terminal proatrial natriuretic peptide in plasma of cats with and without cardiomyopathy." American Journal of Veterinary Research 70(2): 216-222.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library
Join us on Facebook

Biochemical Testing for Feline Heart Disease

Zimmering, T. M., F. Meneses, et al. (2009). "Measurement of N-terminal proatrial natriuretic peptide in plasma of cats with and without cardiomyopathy." American Journal of Veterinary Research 70(2): 216-222.

Nt-proANP is a natriuretic peptide produced in the cardiac muscle cells of the atria. In humans, ANP concentrations are used to distinguish people with chronic heart failure and monitor progression of the disease, survivability, and the efficacy of cardiac interventions. Two recent studies in cats indicated that plasma ANP concentrations were higher in cats with cardiomyopathy (CM) than in healthy cats. This study looked at 43 cats that were divided into three groups: control cats, cats with cardiomyopathy without congestive heart failure (CM without CHF), and cats with cardiomyopathy with congestive heart failure (CM with CHF). All cats had a physical examination, assessment of clinicopathologic variables that included plasma thyroxine concentration, thoracic radiography, and echocardiography. Each cat was assigned to one of the three groups based on results of these findings. A blood sample was taken from all 43 cats for a plasma Nt-proANP concentration using a human ELISA test kit. The first goal of the study was to determine whether Nt-proANP concentrations in cats with CM differ from concentrations in healthy cats. A second goal was to determine if there was a difference in values between cats with CM and no CHF from those cats that had CM with CHF. The results showed significant difference in Nt-proANP concentrations between the control cats that were healthy and the group with CM without CHF. The values were much higher in those cats assessed with CM only. The cats with CM with CHF had even significantly higher concentrations of Nt-proANP than the elevated values noted for the cats with CM and no CHF. Nt-proANP measurement could aid in the assessment of cats with cardiomyopathy and might be useful as a screening marker for the disease. The assay also has the potential for distinguishing between cats with CM without CHF and cats with CM and CHF. [VT]
>> PubMed Abstract

Related articles:
Connolly, D. J., R. J. Soares Magalhaes, et al. (2008). "Circulating natriuretic peptides in cats with heart disease." J Vet Intern Med 22(1): 96-105.
>> PubMed Abstract

Biondo, A. W., E. J. Ehrhart, et al. (2003). "Immunohistochemistry of atrial and brain natriuretic peptides in control cats and cats with hypertrophic cardiomyopathy." Vet Pathol 40(5): 501-6.
>> PubMed Abstract

More on cat health: Winn Feline Foundation Library